Julia Reid

13.5k total citations · 2 hit papers
63 papers, 4.0k citations indexed

About

Julia Reid is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Julia Reid has authored 63 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 27 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Julia Reid's work include Prostate Cancer Treatment and Research (24 papers), Cancer, Lipids, and Metabolism (17 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Julia Reid is often cited by papers focused on Prostate Cancer Treatment and Research (24 papers), Cancer, Lipids, and Metabolism (17 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Julia Reid collaborates with scholars based in United States, Germany and United Kingdom. Julia Reid's co-authors include Jerry S. Lanchbury, Steven Stone, Alexander Gutin, Michael Grace, Matthew H. Samore, Spotswood L. Spruance, Brian E. Ward, Amie M. Deffenbaugh, Thomas Scholl and Dmitry Pruss and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Julia Reid

63 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

2011 548 citations Jack Cuzick, Gregory P. Swanson et al. The Lancet Oncology profile →
Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

2009 529 citations Pierre Laurent‐Puig, Anne Cayre et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Reid United States	22	1.6k	1.3k	1.2k	1.2k	933	63	4.0k
Kathleen A. Cooney United States	41	2.4k 1.5×	1.1k 0.8×	887 0.7×	1.6k 1.4×	1.5k 1.6×	177	5.4k
Christine Lasset France	31	1.3k 0.8×	1.3k 1.0×	977 0.8×	1.4k 1.2×	314 0.3×	99	3.7k
Wenting Wu China	9	1.8k 1.1×	2.7k 2.0×	1.0k 0.8×	1.5k 1.3×	842 0.9×	23	4.0k
Paul Cottu France	36	1.1k 0.7×	2.5k 1.9×	1.8k 1.5×	1.3k 1.1×	325 0.3×	233	5.1k
Jeffrey S. Abrams United States	33	811 0.5×	2.2k 1.7×	1.7k 1.4×	494 0.4×	1.3k 1.3×	104	4.4k
Yutaka Yamamoto Japan	36	743 0.5×	1.7k 1.3×	1.7k 1.4×	1.6k 1.4×	419 0.4×	194	3.9k
Toshinari Yamashita Japan	24	1.6k 1.0×	1.9k 1.5×	1.1k 0.9×	1.3k 1.1×	292 0.3×	135	3.7k
Danny Vesprini Canada	35	2.5k 1.6×	1.0k 0.8×	998 0.8×	1.0k 0.9×	865 0.9×	159	4.9k
Hrafn Tulinius Iceland	38	940 0.6×	1.7k 1.3×	861 0.7×	947 0.8×	1.6k 1.8×	105	5.2k
Hatem A. Azim Belgium	36	689 0.4×	3.6k 2.8×	1.6k 1.3×	1.3k 1.1×	760 0.8×	120	5.5k

Countries citing papers authored by Julia Reid

Since Specialization

Citations

This map shows the geographic impact of Julia Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Reid more than expected).

Fields of papers citing papers by Julia Reid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Reid. The network helps show where Julia Reid may publish in the future.

Co-authorship network of co-authors of Julia Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Reid. A scholar is included among the top collaborators of Julia Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Reid. Julia Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jin, Jing, et al.. (2022). Comparison of OCT imaging in children with foveal hypoplasia born full term versus preterm. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(9). 3075–3085. 2 indexed citations

Reid, Julia, et al.. (2022). “I Don't Have to be Sick to Still Be Worthy”: The Barriers Experienced by Adolescent and Young Adult Cancer Survivors in New Zealand. Journal of Adolescent and Young Adult Oncology. 12(3). 366–375. 1 indexed citations

Christian, Cindy W., et al.. (2022). A baby carrier fall leading to intracranial bleeding and multilayered retinal hemorrhages. Journal of American Association for Pediatric Ophthalmology and Strabismus. 26(2). 84–86. 3 indexed citations

Jin, Jing, et al.. (2021). Effect of gestational age at birth, sex, and race on foveal structure in children. Graefe s Archive for Clinical and Experimental Ophthalmology. 259(10). 3137–3148. 5 indexed citations

Mackley, Amy, et al.. (2020). Do extremely preterm infants need retinopathy of prematurity screening earlier than 31 weeks postmenstrual age?. Journal of Perinatology. 41(2). 305–309. 3 indexed citations

Canter, Daniel, Julia Reid, Shams Halat, et al.. (2018). Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate Cancer. European Urology. 75(3). 515–522. 23 indexed citations

Léon, Priscilla, Géraldine Cancel‐Tassin, Marie Audouin, et al.. (2018). Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy. World Journal of Urology. 36(9). 1495–1500. 19 indexed citations

Patel, Jai N., Elena Ioana Braicu, Kirsten M. Timms, et al.. (2018). Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer. British Journal of Cancer. 119(9). 1060–1066. 38 indexed citations

Binenbaum, Gil, Julia Reid, David L. Rogers, et al.. (2017). Patterns of retinal hemorrhage associated with pediatric cerebral sinovenous thrombosis. Journal of American Association for Pediatric Ophthalmology and Strabismus. 21(1). 23–27. 4 indexed citations

10.

Timms, Kirsten M., Anees B. Chagpar, Vikram B. Wali, et al.. (2016). Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer. Clinical Cancer Research. 23(5). 1193–1199. 26 indexed citations

11.

Reid, Julia, Rachel E. Reem, Shawn C. Aylward, & David L. Rogers. (2016). Sixth Nerve Palsy in Paediatric Intracranial Hypertension. Neuro-Ophthalmology. 40(1). 23–27. 13 indexed citations

12.

Cooperberg, Matthew R., Jeffry Simko, Janet E. Cowan, et al.. (2013). Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort. Journal of Clinical Oncology. 31(11). 1428–1434. 260 indexed citations

13.

Wistuba, Ignacio I., Carmen Behrens, Francesca Lombardi, et al.. (2013). Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma. Clinical Cancer Research. 19(22). 6261–6271. 84 indexed citations

14.

Freedland, Stephen J., Leah Gerber, Julia Reid, et al.. (2013). Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 86(5). 848–853. 143 indexed citations

15.

Cuzick, Jack, Gregory P. Swanson, Gabrielle Fisher, et al.. (2011). Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. The Lancet Oncology. 12(3). 245–255. 548 indexed citations breakdown →

16.

Finger, Paul T., Julia Reid, & Codrin Iacob. (2011). Palladium-103 eye plaque brachytherapy for primary adenocarcinoma of the ciliary body epithelium. Brachytherapy. 10(6). 503–507. 3 indexed citations

17.

Laurent‐Puig, Pierre, Anne Cayre, Gilles Manceau, et al.. (2009). Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer. Journal of Clinical Oncology. 27(35). 5924–5930. 529 indexed citations breakdown →

18.

Stewart, Trina J., Kristy M. Greeneltch, Julia Reid, et al.. (2009). Interferon regulatory factor‐8 modulates the development of tumour‐induced CD11b⁺Gr‐1⁺ myeloid cells. Journal of Cellular and Molecular Medicine. 13(9b). 3939–3950. 41 indexed citations

19.

Hall, Michael J., Julia Reid, Lynn Anne Burbidge, et al.. (2009). BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer. Cancer. 115(10). 2222–2233. 275 indexed citations

20.

Graham, Deborah S. Cunninghame, Harinder Manku, Susanne Wagner, et al.. (2006). Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Human Molecular Genetics. 16(6). 579–591. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact